Aspiro Pharma Limited
FDA inspection history in Siddipet, India, 2021
- 1
- Form 483
Every document, by year
- Form 483
2021: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2021One Form 483, at Siddipet, India.
Cited most
Across all Aspiro Pharma Limited observations on file
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.192Production record review1
The complete Aspiro Pharma Limited file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Siddipet, India
One Form 483 · 2021 · 2 observations
Latest: Form 483, Oct 7, 2021 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2021-10-07 | 483 Form 483 | Siddipet, India | 2 | $99 |
Investigators on these documents
FEI number 3014483338 · most recent document Oct 7, 2021
About Aspiro Pharma Limited
How many FDA Form 483s has Aspiro Pharma Limited received?
FDA Intel has 1 Form 483 on file for Aspiro Pharma Limited; the most recent is dated Oct 7, 2021.
When was Aspiro Pharma Limited last inspected by FDA?
The most recent FDA inspection document on file for Aspiro Pharma Limited is a Form 483 dated Oct 7, 2021, for the site in Siddipet, India.
What did FDA cite at Aspiro Pharma Limited?
The regulations cited most in the observations on file for Aspiro Pharma Limited are 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.192 (Production record review), 1 time.